The Factors Affecting Transplanted Hepatocytes Repopulation in Rats with Liver Fibrosis

간섬유화가 유도된 백서에서 이식된 간세포 착상과 증식에 관여하는 인자

  • Lee, Sang-Woo (Department of Surgery, Yonsei University College of Medicine) ;
  • Min, Seon-Ok (Department of Surgery, Yonsei University College of Medicine) ;
  • Choi, Sae-Byeol (Department of Surgery, Korea University College of Medicine) ;
  • Kim, Kyung-Sik (Department of Surgery, Yonsei University College of Medicine)
  • 이상우 (연세대학교 의과대학 외과학교실) ;
  • 민선옥 (연세대학교 의과대학 외과학교실) ;
  • 최새별 (고려대학교 의과대학 외과학교실) ;
  • 김경식 (연세대학교 의과대학 외과학교실)
  • Published : 2009.12.31

Abstract

Purpose: Cell therapy for various diseases has gained wide acceptance. Because most patients with chronic liver failure have mild-to-severe liver cirrhosis, there are many limitations to clinical applications. We analyzed how to increase cell engraftment in rats with liver fibrosis. Methods: We used analbuminemic SD rats (NARs) as recipients of syngeneic CAG-EGFP SD hepatocytes obtained by the 2 perfusion method. Hepatic fibrosis was induced with thioacetamide in drinking water for 6 weeks in the recipient NARs. NARs were pre-treated with gadolinium, doxorubicin, and gliotoxin before hepatocyte transplantation. We evaluated the degree of cell engraftment by RT-PCR and immunofluorescent staining for GFP and albumin. The transplanted cells were detected by immunostaining for albumin, and serum albumin was also measured. Results: Although detection of GFP by RT-PCR was variable, albumin was detected in all groups 4 wks after hepatocyte transplantation. GFP and albumin were also detected by immunofluorescent staining 1 and 4 wks after cell transplantation. In control rats, albumin production was maximal at 3 wks, and after that it rapidly decreased. In the gadolinium and doxorubicin-treated group, albumin production was increased up to 4 wks. Albumin production in the gadolinium-treated group was superior to that of the doxorubicin-treated group. Conclusion: Kupffer cells play the most important role in cell engraftment in hepatic fibrosis. Therefore, perturbation of kupffer cells in hepatic fibrosis is needed to increase cell engraftment.

Keywords

References

  1. Korean Statistical Information Service. The statistical Results of causes of death in 2008.
  2. Jeong SH. Current status and vaccine indication for hepatitis A virus infection in Korea. Korean J Gastroenterol 2008;51: 331-337.
  3. Gotthardt D, Riediger C, Weiss KH, et al. Fulminant hepatic failure: etiology and indications for liver transplantation. Nephrol Dial Transplant 2007;22(Suppl 8):viii5-8. https://doi.org/10.1093/ndt/gfm650
  4. Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am 1993;22:257-269.
  5. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (2). N Engl J Med 1989;321:1092-1096. https://doi.org/10.1056/NEJM198910193211606
  6. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004;10:440-447. https://doi.org/10.1002/lt.20097
  7. Lee SG, Hwang S, Kim KH, et al. Toward 300 liver transplants a year. Surg Today 2009;39:367-373. https://doi.org/10.1007/s00595-008-3917-1
  8. Grossman M, Raper SE, Kozarsky K, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994;6:335-341. https://doi.org/10.1038/ng0494-335
  9. Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transpl 2000;6:32-40.
  10. Pietrosi G, Vizzini GB, Gruttadauria S, Gridelli B. Clinical applications of hepatocyte transplantation. World J Gastroenterol 2009;15:2074-2077. https://doi.org/10.3748/wjg.15.2074
  11. Kakinuma S, Tanaka Y, Chinzei R, et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 2003;21:217-227. https://doi.org/10.1634/stemcells.21-2-217
  12. Sakaida I. Autologous bone marrow cell infusion therapy for liver cirrhosis. J Gastroenterol Hepatol 2008;23:1349-1353. https://doi.org/10.1111/j.1440-1746.2008.05381.x
  13. Gupta S, Bhargava KK, Novikoff PM. Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation. Semin Liver Dis 1999;19:15-26. https://doi.org/10.1055/s-2007-1007094
  14. Gupta S, Rajvanshi P, Malhi H, et al. Cell transplantation causes loss of gap junctions and activates GGT expression permanently in host liver. Am J Physiol Gastrointest Liver Physiol 2000;279:G815-826. https://doi.org/10.1152/ajpgi.2000.279.4.G815
  15. Kim KS, Joseph B, Inada M, Gupta S. Regulation of hepatocyte engraftment and proliferation after cytotoxic drug-induced perturbation of the rat liver. Transplantation 2005;80:653- 659. https://doi.org/10.1097/01.tp.0000173382.11916.bf
  16. Kobayashi N, Ito M, Nakamura J, et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 2000;31:851-857. https://doi.org/10.1053/he.2000.5636
  17. Wu YM, Gupta S. Hepatic preconditioning for transplanted cell engraftment and proliferation. Methods Mol Biol 2009; 481:107-116.
  18. Nagase S, Shimamune K, Shumiya S. Albumin-deficient rat mutant. Science 1979;205:590-591. https://doi.org/10.1126/science.451621
  19. Shumiya S, Nagase S. Establishment and characteristics of three analbuminemic congenic strains of rats. Jikken Dobutsu 1986;35:409-416.
  20. Gupta S, Rajvanshi P, Lee CD. Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidyl peptidase IV-deficient rats. Proc Natl Acad Sci USA 1995;92:5860-5864. https://doi.org/10.1073/pnas.92.13.5860
  21. Cui FJ, Choi SB, Cho JA, et al. The development of an efficient rat hepatic cirrhosis model. Korean J Hepatobiliary Pancreat Surg 2007;11:46-52.
  22. David P, Alexandre E, Chenard-Neu MP, Wolf P, Jaeck D, Richert L. Failure of liver cirrhosis induction by thioacetamide in nagase analbuminaemic rats. Lab Anim 2002;36:158-164. https://doi.org/10.1258/0023677021912442
  23. Slehria S, Rajvanshi P, Ito Y, et al. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver. Hepatology 2002;35:1320-1328. https://doi.org/10.1053/jhep.2002.33201
  24. Lesage G, Glaser SS, Gubba S, et al. Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. Gastroenterology 1996;111:1633-1644. https://doi.org/10.1016/S0016-5085(96)70027-6
  25. Guha C, Deb NJ, Sappal BS, Ghosh SS, Roy-Chowdhury N, Roy-Chowdhury J. Amplification of engrafted hepatocytes by preparative manipulation of the host liver. Artif Organs 2001; 25:522-528. https://doi.org/10.1046/j.1525-1594.2001.025007522.x
  26. Kumaran V, Joseph B, Benten D, Gupta S. Integrin and extracellular matrix interactions regulate engraftment of transplanted hepatocytes in the rat liver. Gastroenterology 2005; 129:1643-1653. https://doi.org/10.1053/j.gastro.2005.08.006
  27. Joseph B, Malhi H, Bhargava KK, Palestro CJ, McCuskey RS, Gupta S. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology 2002;123:1677-1685. https://doi.org/10.1053/gast.2002.36592
  28. Benten D, Kumaran V, Joseph B, et al. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology 2005; 42:1072-1081. https://doi.org/10.1002/hep.20889
  29. Oren R, Dabeva MD, Petkov PM, Hurston E, Laconi E, Shafritz DA. Restoration of serum albumin levels in nagase analbuminemic rats by hepatocyte transplantation. Hepatology 1999;29:75-81. https://doi.org/10.1002/hep.510290147
  30. Lee KW, Lee JH, Shin SW, et al. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant 2007; 16:629-637. https://doi.org/10.3727/000000007783465019